Case report: Occurrence of hepatocellular carcinoma 4.5 years after successful treatment with virus clearance for chronic hepatitis C

Journal of Gastroenterology and Hepatology (Australia)

Volumn 14, Issue 9, 1999, Pages 928-930

  Miyano, Shintaro ^a   Togashi, Hitoshi ^a   Shinzawa, Haruhide ^a   Sugahara, Kazuhiko ^a   Matsuo, Taku ^a   Takeda, Yoshio ^a   Saito, Koji ^a   Saito, Takafumi ^a   Ishiyama, Shuichi ^a   Kaneko, Masayuki ^b   Takahashi, Tsuneo ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b Department of Pharmacy   (Japan)

Author keywords

Complete response; Hepatitis C virus; Hepatocellular carcinoma; Interferon therapy; Long term follow up

Indexed keywords

ALANINE AMINOTRANSFERASE; RECOMBINANT ALPHA2B INTERFERON;

AGED; ARTICLE; CANCER DIAGNOSIS; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0032887657     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.1999.01954.x     Document Type: Article

References (13)

1. 1 Tamori A, Kuroki T, Nishiguchi S et al. Case of small hepatocellular carcinoma in the caudate lobe detected after interferon caused disappearance of hepatitis C virus. Hepatogastroenterology 1996; 43: 1079-83.
2. 2 Hirashima N, Mizokami M, Orito E et al. Development of hepatocellular carcinoma in a patient with chronic hepatitis C infection after a complete and sustained response to interferon-alpha. J. Gastroenterol. Hepatol. 1996; 11: 955-8.
3. 3 Tong MJ, Lai LP, Murakami-Mori K. Development of hepatocellular carcinoma after clearance of hepatitis C virus with interferon therapy. West. J. Med. 1997; 167: 103-5.
4. 4 Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res. 1996; 6: 986-94.
5. 5 Okamoto H, Okada S, Sugiyama Y et al. The 5′-terminal sequence of the hepatitis C virus genome. Jpn. J. Exp. Med. 1990; 60: 167-77.
6. 6 Liaw YF. Current therapeutic trends in therapy for chronic viral hepatitis. J. Gastroenterol. Hepatol. 1997; 12: 346-53.
7. 7 Sheu JC, Sung JL, Chen DS et al. Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. Gastroenterology 1985; 89: 259-66.
8. 8 Ebara M, Ohto M, Shinagawa T et al. Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in 22 patients. Gastroenterology 1986; 90: 289-98.
9. 9 Tamai T, Seki T, Iriguchi R et al. A case of hepatocellular carcinoma detected four months and four years after IFN treatment for chronic hepatitis C, in spite of showing complete response. Acta Hepatol. Jpn. 1998; 39: 750-5 (in Japanese).
10. 10 Higashitani et al. Acta Hepatol. Jpn. 1997; 38: 134 (Abstract, in Japanese).
11. 11 Maurakami et al. Acta Hepatol. Jpn. 1997; 38: 135 (Abstract, in Japanese).
12. 12 Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 1994; 19: 513-20.
13. 13 The Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Sixth report. Cancer 1987; 60: 1400-11.